Medical Device Company Tandem Diabetes Care Sets Terms for $100 Million IPO

Tandem Diabetes Care, which develops and sells medical devices for insulin-dependent diabetics, announced terms for its IPO on Monday. The San Diego, Calif.-based company plans to raise $100 million by offering 7.1 million shares at a price range of $13 to $15.
Renaissance Capital